Publication | Open Access
Panitumumab Plus Trifluridine-Tipiracil as Anti–Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory <i>RAS</i> Wild-Type Metastatic Colorectal Cancer
53
Citations
10
References
2023
Year
ClinicalTrials.gov Identifier: NCT05468892.
| Year | Citations | |
|---|---|---|
Page 1
Page 1